Abstract

Background:

Prolonged mechanical ventilation is associated with muscle weakness, pharyngeal dysfunction, and symptomatic aspiration. The authors hypothesized that muscle strength measurements can be used to predict pharyngeal dysfunction (endoscopic evaluation–primary hypothesis), as well as symptomatic aspiration occurring during a 3-month follow-up period.

Methods:

Thirty long-term ventilated patients admitted in two intensive care units at Massachusetts General Hospital were included. The authors conducted a fiberoptic endoscopic evaluation of swallowing and measured muscle strength using medical research council score within 24 h of each fiberoptic endoscopic evaluation of swallowing. A medical research council score less than 48 was considered clinically meaningful muscle weakness. A retrospective chart review was conducted to identify symptomatic aspiration events.

Results:

Muscle weakness predicted pharyngeal dysfunction, defined as either valleculae and pyriform sinus residue scale of more than 1, or penetration aspiration scale of more than 1. Area under the curve of the receiver-operating curves for muscle strength (medical research council score) to predict pharyngeal, valleculae, and pyriform sinus residue scale of more than 1, penetration aspiration scale of more than 1, and symptomatic aspiration were 0.77 (95% CI, 0.63–0.97; P = 0.012), 0.79 (95% CI, 0.56–1; P = 0.02), and 0.74 (95% CI, 0.56–0.93; P = 0.02), respectively. Seventy percent of patients with muscle weakness showed symptomatic aspiration events. Muscle weakness was associated with an almost 10-fold increase in the symptomatic aspiration risk (odds ratio = 9.8; 95% CI, 1.6–60; P = 0.009).

Conclusion:

In critically ill patients, muscle weakness is an independent predictor of pharyngeal dysfunction and symptomatic aspiration. Manual muscle strength testing may help identify patients at risk of symptomatic aspiration.

What We Already Know about This Topic
  • Swallowing dysfunction after long-term ventilation can lead to aspiration pneumonia, but is clinically difficult to be diagnosed without the use of instrumental swallowing studies such as fiberoptic endoscopy or videofluoroscopy

What This Article Tells Us That Is New
  • In 30 critically ill adult patients mechanically ventilated more than 10 days, extremity muscle weakness assessed by medical research council score was an independent predictor of swallowing dysfunction and symptomatic aspiration after extubation

DYSPHAGIA occurs frequently following long-term ventilation of critically ill patients1  and this can result in an increased risk of symptomatic aspiration.2,3  Using videofluoroscopic swallow evaluation, it has been reported that 50% of the prolonged ventilated patients aspirate,2  the majority of them silently.2,4  Symptomatic aspiration (typically presenting as pneumonitis or pneumonia) is an important mechanism of acute lung injury, which translates to weaning failure,4  delayed hospital discharge, and mortality.5,6 

It is unclear how to clinically identify patients at risk of aspiration. Data suggest that a variety of conditions including, but not limited to, decreased level of consciousness,7,8  motor neuronal diseases,9–11  inadequate cough,12  structural abnormalities of the pharynx or larynx, and a history of chemotherapy13  or radiotherapy14  contribute to the risk of aspiration. Fiberoptic endoscopic evaluation of swallowing (FEES) can be performed at the bedside to predict a patient’s ability to protect the airway, but the test is resource intensive and cannot be routinely applied for daily screening of long-term ventilated patients.15 

Muscle weakness is common in intensive care unit (ICU) patients16–18  and predicts ICU length of stay, and mortality.19–21  Importantly, airway muscle weakness is a common mechanism of dysphagia,22,23  and dysphagia predisposes patients to aspiration as demonstrated in patients with amyotrophic lateral sclerosis.24  We hypothesized that clinical muscle strength assessment is associated with pharyngeal dysfunction identified during endoscopic evaluation (primary criterion) and predicts symptomatic aspiration 3 months after the strength measurement (secondary criterion).

Materials and Methods

This was a prospective observational study performed in the Respiratory Acute Care Unit and the Surgical ICU at Massachusetts General Hospital. The study was approved by the Partners institutional review board (Boston, Massachusetts). Written informed consent was obtained from each patient or patient’s healthcare proxy.

Subjects

From January 2011 to April 2012, 30 long-term ventilated subjects were recruited. All patients who had been consulted for FEES during the observation period and met the inclusion criteria of the study were approached for the consent (fig. 1). Patients were included in the study if they were: 18 yr old or more, ventilated for more than 10 days,25  and underwent a FEES performed by a speech-language pathologist. Patients were excluded from the study if they had: a Richmond Agitation Sedation Scale of less than 0, signs and symptoms of delirium according to the confusion assessment method, degenerative neurological disease, known structural abnormalities of the larynx/pharynx, a history of chemotherapy or radiotherapy to the head or neck, multiorgan dysfunction or failure, or were pregnant. Patients were also excluded from the study if structural abnormalities of the larynx/pharynx were identified during the FEES.

Fig. 1.

Subject progression through the study algorithm. We enrolled consecutive patients who presented to our speech and swallow therapists for evaluation of readiness for oral food intake. After screening these patients for inclusion criteria, and obtaining their approval, dysphagia potential was assessed by fiberoptic endoscopic evaluation of swallowing (FEES), and graded using validated rating scales. *Muscle strength was measured by an investigator blinded to FEES results within 24 h of FEES. A chart review was then performed following subjects’ hospital discharge to identify signs and symptoms of symptomatic aspiration in the 3 months after FEES. MRC = medical research council scale; PAS = Penetration Aspiration Scale; VPSR = valleculae and pyriform sinus residue scale.

Fig. 1.

Subject progression through the study algorithm. We enrolled consecutive patients who presented to our speech and swallow therapists for evaluation of readiness for oral food intake. After screening these patients for inclusion criteria, and obtaining their approval, dysphagia potential was assessed by fiberoptic endoscopic evaluation of swallowing (FEES), and graded using validated rating scales. *Muscle strength was measured by an investigator blinded to FEES results within 24 h of FEES. A chart review was then performed following subjects’ hospital discharge to identify signs and symptoms of symptomatic aspiration in the 3 months after FEES. MRC = medical research council scale; PAS = Penetration Aspiration Scale; VPSR = valleculae and pyriform sinus residue scale.

We recorded the following variables: age, sex, body mass index, Charlson Comorbidity Index, duration of mechanical ventilation (intubation and tracheostomy; mode of mechanical ventilation), ICU length of stay, hospital length of stay before and after FEES, confusion assessment method score, Richmond Agitation Sedation Scale score, albumin, leukocyte count, nasogastric tube presence, presence of a percutaneous endoscopic gastrostomy tube, diabetes mellitus diagnosis, and sepsis at the time of FEES.

Measurement of Pharyngeal Dysfunction: FEES

FEES equipment consisted of a 3.4-mm diameter adult flexible fiberoptic rhinolaryngoscope (FNL-10RP3, Pentax, Montvale, NJ), light source (LH-150PC, Pentax), camera (PSV-4000, Pentax), and color monitor (model AL1715, Acer, San Jose, CA).

Valleculae and pyriform sinus residue scale (VPSR scale; numeric rating scale: 0–4) was used to quantify pharyngeal swallowing and clearing of secretions. The VPSR has five grades: 0 is no residue; 1 is residue covers less than 10% of all width of valleculae or pyriform sinuses; 2 and 3 are assigned if residue covers from more than 10% to less than 50%; 4 is if residue covers more than 50%.26 

The penetration aspiration scale (PAS; numeric rating scale: 1–8) was used to quantify a patient’s ability to protect his airway during FEES.15,27  The PAS is an ordinal scale consisting of eight scores based on compared observations. A score of 1 indicates normal protection of the upper airway during a swallow with no food residue entering into the airway. Scores between 2 and 8 demonstrate abnormal swallowing, and as the grade increases so does the severity of dysphagia with food residue entering further into the airway. Scores between 2 and 5 are considered “penetration” such that residue stays above the vocal folds (scores 2 and 3), or courses to the level of vocal folds (scores 4 and 5) but no further. Scores between 6 and 8 are considered “aspiration” as the materials passes below the vocal folds. Whether or not material is ejected from the airway with the effort made also contributes to the judgement of severity of aspiration (for examples, please see fig. 2 and the video provided as Supplemental Digital Content 1, http://links.lww.com/ALN/A927).

Fig. 2.

Images taken by fiberoptic endoscopic evaluation of swallowing. Severity of pharyngeal dysphagia was assessed using previously validated scales. The liquid milk bolus of 3 cc was impregnated with blue food coloring for optimal visualization. Please find the corresponding video in Supplemental Digital Content 1, http://links.lww.com/ALN/A927. (A) A normal swallow. No entrance of the bolus into airway with minimal residue after swallow. (B) Less than 50% residue remaining after swallow. The entrance of liquid into the airway can be visualized in the movie published online. (C) Entrance of liquid into the airway below the vocal cords with more than 50% residue remaining after swallow.

Fig. 2.

Images taken by fiberoptic endoscopic evaluation of swallowing. Severity of pharyngeal dysphagia was assessed using previously validated scales. The liquid milk bolus of 3 cc was impregnated with blue food coloring for optimal visualization. Please find the corresponding video in Supplemental Digital Content 1, http://links.lww.com/ALN/A927. (A) A normal swallow. No entrance of the bolus into airway with minimal residue after swallow. (B) Less than 50% residue remaining after swallow. The entrance of liquid into the airway can be visualized in the movie published online. (C) Entrance of liquid into the airway below the vocal cords with more than 50% residue remaining after swallow.

The swallowing consult was requested by the subject’s critical care team. Swallowing evaluation and FEES were performed at the bedside by one of two experienced speech-language pathologists. According to departmental guidelines, a swallowing evaluation is only performed on a patient who has the potential to receive an oral diet based on the clinical assessment of the care team but is suspected of being at risk of aspiration and aspiration-related morbidity. Additionally, the patient must be capable of cooperating with the speech-language pathologist throughout the study.

Before the FEES, the subject was placed in an upright position, and the endoscope was passed transnasally into the velopharynx. No topical anesthesia was administered to the nasal mucosa. The tip of the scope was held in “high position,” below the velopharyngeal port and above the epiglottis,28  in order to view the entire pharynx and larynx. All food was impregnated with blue food coloring (SteriBlu FD&C Blue No. 1; Nestle´ Clinical Nutrition, Inc., Deerfield, IL) for optimal visualization. Before administration of food and liquid boluses, a preswallow secretion assessment was taken to evaluate the amount of baseline secretions in the pharynx and larynx. VPSR and PAS measurements were taken from the initial liquid bolus (3–5 ml milk). If indicated, the patients received other consistencies as part of the clinical diagnostic evaluation. The FEES was digitally recorded for later interobserver evaluation of VPSR and PAS measures by the speech-language pathologists.

The main outcome of the FEES was laryngeal penetration with increased risk of aspiration, defined as either (1) abnormal bolus retention in the valleculae and pyriform sinuses after the pharyngeal swallow (VPSR > grade 1), or (2) material entrance to the airway (PAS > score 1).

Muscle Strength Evaluation

Muscle strength measurement was performed within 24 h of the FEES.

Muscle Testing with the Medical Research Council (MRC) Score

The MRC scale29  is a clinical assessment of muscle power and assigns a score of 0 (no movement) to 5 (normal muscle strength) for six validated movements (abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the hip, extension of the knee, and dorsal flexion of the foot) on each side of the body. The sum of the scores for all movements provides a total score out of a possible 60 points. All the subjects’ MRC scores were assessed by a single, trained observer (physician) blinded to the results of FEES.

Grip Strength

If a MRC score of 3 or greater was observed for bilateral wrist extension and forearm flexion, subject’s handgrip strength was measured in the dominant hand, using a calibrated hydraulic handgrip dynamometer (Jamar handgrip dynamometer; Sammons Preston Rolyan, Bolingbrook, IL). The assessment was done three times and the average value was used for the measure of grip strength. An observer supported the device manually during measurements and care was taken to perform measurements with the elbow at 90° flexion.30 

Assessment of Symptomatic Aspiration

Two blinded physicians reviewed the charts for the diagnosis or possibility, of symptomatic aspiration. Symptomatic aspiration was defined as aspiration accompanied by acute symptoms of coughing, choking, shortness of breath, or respiratory distress with or without confirmed signs of aspiration by a chest radiograph.31  Patients with symptomatic aspiration were followed-up by chart review to identify clinical sequellae occurring within 3 months of the FEES.

Statistical Analysis

The primary outcome (endpoint) was pharyngeal dysfunction determined by FEES. We tested the hypotheses that MRC-derived diagnosis of muscle weakness (MRC score <48)32  predicts (1) abnormal bolus retention in the valleculae and pyriform sinuses after the pharyngeal swallow (VPSR > grade 1, primary), and (2) material entrance to the airway (PAS > score 1, coprimary). We tested the secondary hypothesis that a MRC score less than 48 predicts symptomatic aspiration. We also tested the hypothesis that pharyngeal dysfunction based on FEES is associated with symptomatic aspiration.

For power analysis, we expected a correlation of 0.5 between the MRC-derived muscle strength (MRC <48) and FEES-drived values (PAS score and VPSR grade >1). Accordingly, we calculated that a sample size of 30 patients will provide a power of more than 0.80 to detect a difference of −0.5 between the null hypothesis correlation of 0 and the alternative hypothesis correlation of 0.5, using a two-sided hypothesis test with a significance level of 0.05. Logistic regression analysis was used for hypothesis testing and to identify additional predictors of outcome. Statistical calculations were made using IBM SPSS Statistics for Windows, Version 19.0 (IBM Corp., Armonk, NY), Hintze J. (2011) PASS 11 (NCSS, LLC., Kaysville, UT), and Sigma Plot Version 12.3 (Systat Software, San Jose, CA). Data were presented in mean ± SD and a P value less than 0.05 was considered as significant.

Two speech and swallow therapists reviewed all the video-recorded FEES and rerated them. κ Statistic was performed to determine consistency among raters for VPSR and PAS.

Results

Data from 16 men and 14 women was included. The subjects’ mean age was 55 ± 14 yr (range 35–66 yr). The subjects’ mean duration of mechanical ventilation was 136 ± 423 days.

Main Outcome Criteria

Effects of Muscle Weakness on Pharyngeal Dysfunction

Muscle weakness (defined as MRC score <48)32  was associated with a 5.4-fold (95% CI, 1–28.5; P = 0.014) and 9-fold (95% CI, 1.3–61.14; P = 0.038) increased risk of pharyngeal dysfunction, defined as VPSR and PAS grades more than 1. Positive and negative predictive values of muscle weakness for PAS more than 1 or VPSR scale more than 1 (pharyngeal dysfunction) were 90 and 46%, respectively. The calculated area under the curve of the receiver-operating curve for MRC score to predict VPSR grade more than 1 and PAS more than 1 was 0.77 (95% CI, 0.63–0.97; P = 0.012), and 0.79 (95% CI, 0.56–1; P = 0.02; fig. 3, A and B), respectively.

Fig. 3.

Receiver-operating characteristic curves of medical research council scale for pharyngeal dysfunction (valleculae and pyriform sinus residue scale or penetration aspiration scale >1) and occurrence of aspiration in 3-month follow-up. (A) Valleculae and pyriform sinus residue scale grade more than 1 (area under the curve = 0.77; 95% CI, 0.63–0.97; P = 0.012). (B) Penetration aspiration scale more than 1 (area under the curve = 0.80; 95% CI, 0.56–1; P = 0.02). (C) Development of aspiration (area under the curve = 0.74; 95% CI, 0.56–0.93; P = 0.02).

Fig. 3.

Receiver-operating characteristic curves of medical research council scale for pharyngeal dysfunction (valleculae and pyriform sinus residue scale or penetration aspiration scale >1) and occurrence of aspiration in 3-month follow-up. (A) Valleculae and pyriform sinus residue scale grade more than 1 (area under the curve = 0.77; 95% CI, 0.63–0.97; P = 0.012). (B) Penetration aspiration scale more than 1 (area under the curve = 0.80; 95% CI, 0.56–1; P = 0.02). (C) Development of aspiration (area under the curve = 0.74; 95% CI, 0.56–0.93; P = 0.02).

Other independent variables evaluated for confounder control (age, weight, leukocyte count, sex, body mass index, albumin, grip strength, ICU length of stay before testing, diabetes, or the presence of a nasogastric tube) did not predict pharyngeal dysfunction.

Secondary Outcome Criterion

Effects of Muscle Weakness on Symptomatic Aspiration Events

Logistic regression revealed the following variables to be associated with symptomatic aspiration events: muscle strength measured by MRC (area under the curve = 0.74 [95% CI, 0.56–0.93]; odds ratio = 0.864 [95% CI, 0.86–0.87]; P = 0.02; fig. 3C), PAS score more than 1 (P = 0.025), grip strength (P = 0.04), and duration of mechanical ventilation (P = 0.027).

Addition of the variable “duration of mechanical ventilation” to the logistic regression model, revealed that both MRC and PAS score more than 1 explained significant variance of symptomatic aspiration, independent of the duration of mechanical ventilation (P = 0.045 and 0.037, respectively). Of note, muscle weakness (MRC <48) was associated with a 10-fold increased risk of a symptomatic aspiration event (odds ratio = 9.75; 95% CI, 1.6–60; P = 0.009; table 1). The MRC threshold for muscle weakness at 48 is estimated to have a sensitivity of 93% (95% CI, 66–99) for prediction of symptomatic aspiration and specificity of 60% (95% CI, 33–82). These values yield a positive likelihood ratio of 2.3 and a negative likelihood ratio of 0.11 with a posttest probability of 70%.

Table 1.

Baseline Demographic and Clinical Characteristics

Baseline Demographic and Clinical Characteristics
Baseline Demographic and Clinical Characteristics

Grip Strength

Grip strength (2 ± 4, range 0–18 kg) was associated with MRC (45.5 ± 8.3, 25–59 [r = 0.5; P = 0.005]). However, grip strength values predicted neither risk of aspiration (VPSR >1 and PAS >1), nor incidence of aspiration after adjustment for MRC, mechanical ventilation, and PAS (P > 0.05).

Reliability Assessment

κ Statistics revealed outstanding and substantial indicators of agreement between the two speech-language pathologists during their assessment of aspiration risk using VPRS (0.816, 95% CI, 0.694–0.937; P < 0.001) and PAS (0.907, 95% CI, 0.738–1; P < 0.001).

Discussion

In critically ill patients, muscle weakness is an independent predictor of pharyngeal dysfunction as well as symptomatic aspiration. Pharyngeal dysfunction is also associated with symptomatic aspiration, suggesting that the link between muscle weakness and aspiration can in part be explained by pharyngeal dysfunction.

ICU-acquired muscle weakness affects weaning from the ventilator, it increases length of stay in the ICU and the hospital, and translates to long-term morbidity.33–35  An association between ICU-acquired muscle weakness and pharyngeal dysphagia leading to aspiration likely contributes to such poor clinical outcomes. Notably, aspiration does not always lead to pathology and can remain asymptomatic or “silent.” For example, 45% of individuals aspirate during sleep, and 70% of patients aspirate during periods of impaired consciousness.8  Therefore, we evaluated both the incidence of aspiration, through FEES, and the incidence of its more clinically meaningful outcome, i.e., symptomatic aspiration.31,36 

Muscle weakness is associated with increased aspiration risk. For example, in amyotrophic lateral sclerosis, pathological diffuse muscle weakness can affect the ability to protect the airway while swallowing and dysphagia is frequently reported.37,38  Even at the time of diagnosis of amyotrophic lateral sclerosis more than 50% of patients present with pharyngeal dysfunction identified by FEES.24  In our long-term ventilated patients in the ICU, two thirds presented with clinically meaningful weakness, and this agrees with the observations of others.39,40 

In our sample, 70% of subjects with clinical muscle weakness had a meaningful aspiration event, whereas only 10% of subjects without clinical muscle weakness had such an occurrence. Given the study population, perhaps more important variables are the positive and negative predictive values of MRC score for the prediction of symptomatic aspiration: 70 and 90%, respectively. These results suggest clinical muscle weakness, measured by manual muscle strength testing, is useful in screening and stratifying patients into those with high or low aspiration risk, but that absence of clinical muscle weakness does not preclude the probability of aspiration. It is noted that the etiology of aspiration after prolonged ventilation is usually multifactorial. The presence of other risk factors, such as impaired cough during tracheal suctioning, should warrant additional diagnostic measures, such as a FEES exam to identify all patients needing global aspiration precautions.

We identified clinically meaningful muscle weakness through a MRC score of less than 48,30,32  and measured grip strength, an easily assessable variable, which has been associated with hospital mortality.19  In our study, grip strength correlated significantly with muscle weakness as assessed by MRC, but did not predict pharyngeal dysphagia or symptomatic aspiration. Similar to our finding, Butler et al.41  did not find an association between grip strength and aspiration—even though grip strength correlated in their study with isometric tongue strength, which in turn was associated with aspiration risk. On the basis of these findings and recent data in critically ill patients reported by our group20,42  and others,43  we concluded that grip strength may not be able to reflect small variation in muscle strength in patients with reduced muscle strength.

We controlled for confounders by evaluating the effects of other known predictors of aspiration and including them in our statistical model. We considered Charlson Comorbidity Index, albumin, length of mechanical ventilation, leukocyte count, sepsis, and length of stay, all of which have been associated with aspiration risk or muscle weakness.32,44–46  In our study, in accordance with others, we identified an association between duration of mechanical ventilation and aspiration risk2,47 ; however, when clinically significant muscle weakness was added as a covariate, this association became insignificant.

In the ICU setting, symptomatic aspiration is the leading cause of pneumonia, and contributes significantly to the overall morbidity and mortality.48  In the perioperative setting, aspiration is the third most common reason for reintubation and subsequent unplanned ICU admission, a situation that has been associated with a 90-fold increase of in-hospital mortality.49  In our study, muscle weakness was associated with both pharyngeal dysfunction, and symptomatic aspiration and its clinical sequellae (fig. 4). In addition, variables of pharyngeal dysfunction (PAS > score 1 or VPSR > score 1) were associated with symptomatic aspiration. This combination of findings suggests that muscle weakness may increase the risk of symptomatic aspiration by affecting the pharyngeal muscles involved in swallowing. This suggestion is also supported by the findings of Butler et al.,41  who reported that isometric tongue strength, and not grip strength, is associated with aspiration risk.

Fig. 4.

Consequences of symptomatic aspiration (muscle weakness: n = 14 and no muscle weakness: n = 1). Aspiration-related sequellae were classified according to the North American Summit on Aspiration in the Critically Ill Patients consensus statement; ARDS = acute respiratory distress syndrome.

Fig. 4.

Consequences of symptomatic aspiration (muscle weakness: n = 14 and no muscle weakness: n = 1). Aspiration-related sequellae were classified according to the North American Summit on Aspiration in the Critically Ill Patients consensus statement; ARDS = acute respiratory distress syndrome.

Stratifying patients by aspiration risk allows physicians to better identify those who will benefit from aspiration precautions. Moreover, patients identified as higher risk secondary to muscle weakness can be selected for further individualized assessments with the aim of safe and adequate nutrition.50  The additional assessments may involve bedside FEES or radiological evaluations, to assist in deciding which interventions are most appropriate, and may include: direct exercises (practicing correct swallows with food boluses), indirect exercises (strengthening neuromotor controls and the swallowing process without food),50,51  rehabilitative measures such as swallow therapy,52  and dietary modifications specific to the patient’s swallowing ability.50,53 

Muscle strength is not the only factor leading to proper swallowing. In swallowing, the human larynx closes, elevates, and arcs anteriorly under the tongue; this expands the hypopharyngeal space and opens the upper esophageal sphincter. The epiglottis folds posteriorly over the laryngeal aditus and directs the ingested bolus into the pyriform recesses toward the now relaxed upper esophageal sphincter. Airflow ceases as the bolus moves through the hypopharynx.54  Accordingly, in swallowing, a combination of adequate sensing, intact protective aerodigestive reflexes, along with pharyngeal muscle strength are required to maintain a patent airway.54  This highlights the fact that absence of weakness cannot predict absence of swallowing dysfunction.

In accordance with others,55–57  we used FEES to make the diagnosis of pharyngeal dysfunction. In our hospital, as well as elsewhere, FEES is used as a bedside evaluation to identify patients at high risk of aspiration. It is a valid alternative method to define the optimal time to initiate oral feeding in critically ill patients, who have endured prolonged mechanical ventilation with the advantages of reproducibility, minimal risk, and discomfort.1,55,56  However, a videofluoroscopic swallowing study, also referred to as the modified barium swallow, has been considered the “gold standard” for the evaluation of a swallowing disorder.58  Videofluoroscopic swallowing study requires the transport of critically ill patients (e.g., ventilator-dependent patients) outside the ICU,58  which limits the feasibility to be used as a bedside-diagnostic test in critically ill patients. FEES has increasingly been used as a bedside assessment tool59  to evaluate the aspiration risk.60,61 

The limitations of our study included the absence of a baseline swallowing study, selection bias, and small sample size. The association between muscle weakness and aspiration risk was studied in a collective of patients with high pretest probability of aspiration, which needs to be taken into account when interpreting our findings. Our sample size was relatively small and the number of outcomes few. Therefore, it is not possible to perform a rigorous multivariate regression analysis to fully account for the factors that might confound a causal relationship between muscle weakness and aspiration.

Our study was powered for FEES-derived evidence of pharyngeal dysfunction (a well-defined endpoint). Our secondary clinical outcome was “symptomatic aspiration.” On the basis of the data we present here, we are now able to power our next trial on the association of muscle weakness and symptomatic aspiration—including a higher sample size and a broader range of muscle strength values for comparison. Accordingly, we conclude that the observed association between muscle weakness and symptomatic aspiration should be considered “hypothesis-generating” rather than “proven.”

In critically ill patients, muscle weakness is an independent predictor of pharyngeal dysfunction as well as symptomatic aspiration. Pharyngeal dysfunction is also associated with symptomatic aspiration, suggesting that the link between muscle weakness and aspiration can, in part, be explained by pharyngeal dysfunction.

References

References
1.
Hafner
G
,
Neuhuber
A
,
Hirtenfelder
S
,
Schmedler
B
,
Eckel
HE
:
Fiberoptic endoscopic evaluation of swallowing in intensive care unit patients.
Eur Arch Otorhinolaryngol
2008
;
265
:
441
6
2.
Elpern
EH
,
Scott
MG
,
Petro
L
,
Ries
MH
:
Pulmonary aspiration in mechanically ventilated patients with tracheostomies.
Chest
1994
;
105
:
563
6
3.
DeVita
MA
,
Spierer-Rundback
L
:
Swallowing disorders in patients with prolonged orotracheal intubation or tracheostomy tubes.
Crit Care Med
1990
;
18
:
1328
30
4.
Elpern
EH
,
Jacobs
ER
,
Bone
RC
:
Incidence of aspiration in tracheally intubated adults.
Heart Lung
1987
;
16
:
527
31
5.
Rubenfeld
GD
,
Caldwell
E
,
Peabody
E
,
Weaver
J
,
Martin
DP
,
Neff
M
,
Stern
EJ
,
Hudson
LD
:
Incidence and outcomes of acute lung injury.
N Engl J Med
2005
;
353
:
1685
93
6.
Barker
J
,
Martino
R
,
Reichardt
B
,
Hickey
EJ
,
Ralph-Edwards
A
:
Incidence and impact of dysphagia in patients receiving prolonged endotracheal intubation after cardiac surgery.
Can J Surg
2009
;
52
:
119
24
7.
Metheny
NA
:
Risk factors for aspiration.
JPEN J Parenter Enteral Nutr
2002
;
26
(
6 suppl
):
S26
31; discussion S32–3
8.
Huxley
EJ
,
Viroslav
J
,
Gray
WR
,
Pierce
AK
:
Pharyngeal aspiration in normal adults and patients with depressed consciousness.
Am J Med
1978
;
64
:
564
8
9.
Holas
MA
,
DePippo
KL
,
Reding
MJ
:
Aspiration and relative risk of medical complications following stroke.
Arch Neurol
1994
;
51
:
1051
3
10.
Dray
TG
,
Hillel
AD
,
Miller
RM
:
Dysphagia caused by neurologic deficits.
Otolaryngol Clin North Am
1998
;
31
:
507
24
11.
Leopold
NA
,
Kagel
MC
:
Dysphagia—Ingestion or deglutition?: A proposed paradigm.
Dysphagia
1997
;
12
:
202
6
12.
Sekizawa
K
,
Ujiie
Y
,
Itabashi
S
,
Sasaki
H
,
Takishima
T
:
Lack of cough reflex in aspiration pneumonia.
Lancet
1990
;
335
:
1228
9
13.
Nguyen
NP
,
Moltz
CC
,
Frank
C
,
Vos
P
,
Millar
C
,
Smith
HJ
,
Lee
H
,
Karlsson
U
,
Nguyen
PD
,
Martinez
T
,
Nguyen
LM
,
Sallah
S
:
Aspiration rate following nonsurgical therapy for laryngeal cancer.
ORL J Otorhinolaryngol Relat Spec
2007
;
69
:
116
20
14.
Pauloski
BR
,
Rademaker
AW
,
Logemann
JA
,
Stein
D
,
Beery
Q
,
Newman
L
,
Hanchett
C
,
Tusant
S
,
MacCracken
E
:
Pretreatment swallowing function in patients with head and neck cancer.
Head Neck
2000
;
22
:
474
82
15.
Butler
SG
,
Stuart
A
,
Markley
L
,
Rees
C
:
Penetration and aspiration in healthy older adults as assessed during endoscopic evaluation of swallowing.
Ann Otol Rhinol Laryngol
2009
;
118
:
190
8
16.
Lacomis
D
:
Neuromuscular disorders in critically ill patients: Review and update.
J Clin Neuromuscul Dis
2011
;
12
:
197
218
17.
Deem
S
:
Intensive-care-unit-acquired muscle weakness.
Respir Care
2006
;
51
:
1042
52; discussion 1052–3
18.
Hermans
G
,
De Jonghe
B
,
Bruyninckx
F
,
Van den Berghe
G
:
Clinical review: Critical illness polyneuropathy and myopathy.
Crit Care
2008
;
12
:
238
19.
Ali
NA
,
O’Brien
JM
Jr
,
Hoffmann
SP
,
Phillips
G
,
Garland
A
,
Finley
JC
,
Almoosa
K
,
Hejal
R
,
Wolf
KM
,
Lemeshow
S
,
Connors
AF
Jr
,
Marsh
CB
;
Midwest Critical Care Consortium
:
Acquired weakness, handgrip strength, and mortality in critically ill patients.
Am J Respir Crit Care Med
2008
;
178
:
261
8
20.
Kasotakis
G
,
Schmidt
U
,
Perry
D
,
Grosse-Sundrup
M
,
Benjamin
J
,
Ryan
C
,
Tully
S
,
Hirschberg
R
,
Waak
K
,
Velmahos
G
,
Bittner
EA
,
Zafonte
R
,
Cobb
JP
,
Eikermann
M
:
The surgical intensive care unit optimal mobility score predicts mortality and length of stay.
Crit Care Med
2012
;
40
:
1122
8
21.
Latronico
N
,
Shehu
I
,
Seghelini
E
:
Neuromuscular sequelae of critical illness.
Curr Opin Crit Care
2005
;
11
:
381
90
22.
Loeb
M
,
McGeer
A
,
McArthur
M
,
Walter
S
,
Simor
AE
:
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities.
Arch Intern Med
1999
;
159
:
2058
64
23.
Smithard
DG
,
O’Neill
PA
,
Parks
C
,
Morris
J
:
Complications and outcome after acute stroke. Does dysphagia matter?
Stroke
1996
;
27
:
1200
4
24.
Leder
SB
,
Novella
S
,
Patwa
H
:
Use of fiberoptic endoscopic evaluation of swallowing (FEES) in patients with amyotrophic lateral sclerosis.
Dysphagia
2004
;
19
:
177
81
25.
Morganroth
ML
,
Morganroth
JL
,
Nett
LM
,
Petty
TL
:
Criteria for weaning from prolonged mechanical ventilation.
Arch Intern Med
1984
;
144
:
1012
6
26.
Han
TR
,
Paik
NJ
,
Park
JW
:
Quantifying swallowing function after stroke: A functional dysphagia scale based on videofluoroscopic studies.
Arch Phys Med Rehabil
2001
;
82
:
677
82
27.
Rosenbek
JC
,
Robbins
JA
,
Roecker
EB
,
Coyle
JL
,
Wood
JL
:
A penetration-aspiration scale.
Dysphagia
1996
;
11
:
93
8
28.
Suiter
DM
,
Moorhead
MK
:
Effects of flexible fiberoptic endoscopy on pharyngeal swallow physiology.
Otolaryngol Head Neck Surg
2007
;
137
:
956
8
29.
Kleyweg
RP
,
van der Meché
FG
,
Schmitz
PI
:
Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.
Muscle Nerve
1991
;
14
:
1103
9
30.
Hermans
G
,
Clerckx
B
,
Vanhullebusch
T
,
Segers
J
,
Vanpee
G
,
Robbeets
C
,
Casaer
MP
,
Wouters
P
,
Gosselink
R
,
Van Den Berghe
G
:
Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit.
Muscle Nerve
2012
;
45
:
18
25
31.
McClave
SA
,
DeMeo
MT
,
DeLegge
MH
,
DiSario
JA
,
Heyland
DK
,
Maloney
JP
,
Metheny
NA
,
Moore
FA
,
Scolapio
JS
,
Spain
DA
,
Zaloga
GP
:
North American Summit on Aspiration in the Critically Ill Patient: Consensus statement.
JPEN J Parenter Enteral Nutr
2002
;
26
(
6 suppl
):
S80
5
32.
De Jonghe
B
,
Sharshar
T
,
Lefaucheur
JP
,
Authier
FJ
,
Durand-Zaleski
I
,
Boussarsar
M
,
Cerf
C
,
Renaud
E
,
Mesrati
F
,
Carlet
J
,
Raphaël
JC
,
Outin
H
,
Bastuji-Garin
S
;
Groupe de Réflexion et d’Etude des Neuromyopathies en Réanimation
:
Paresis acquired in the intensive care unit: A prospective multicenter study.
JAMA
2002
;
288
:
2859
67
33.
De Jonghe
B
,
Bastuji-Garin
S
,
Sharshar
T
,
Outin
H
,
Brochard
L
:
Does ICU-acquired paresis lengthen weaning from mechanical ventilation?
Intensive Care Med
2004
;
30
:
1117
21
34.
Bittner
EA
,
Martyn
JA
,
George
E
,
Frontera
WR
,
Eikermann
M
:
Measurement of muscle strength in the intensive care unit.
Crit Care Med
2009
;
37
(
10 suppl
):
S321
30
35.
Truong
AD
,
Fan
E
,
Brower
RG
,
Needham
DM
:
Bench-to-bedside review: Mobilizing patients in the intensive care unit—From pathophysiology to clinical trials.
Crit Care
2009
;
13
:
216
36.
Kalinowski
CP
,
Kirsch
JR
:
Strategies for prophylaxis and treatment for aspiration.
Best Pract Res Clin Anaesthesiol
2004
;
18
:
719
37
37.
Strand
EA
,
Miller
RM
,
Yorkston
KM
,
Hillel
AD
:
Management of oral-pharyngeal dysphagia symptoms in amyotrophic lateral sclerosis.
Dysphagia
1996
;
11
:
129
39
38.
Sonies
BC
:
Patterns of care for dysphagic patients with degenerative neurological diseases.
Semin Speech Lang
2000
;
21
:
333
44; quiz 334–5
39.
Leijten
FS
,
Harinck-de Weerd
JE
,
Poortvliet
DC
,
de Weerd
AW
:
The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation.
JAMA
1995
;
274
:
1221
5
40.
Berek
K
,
Margreiter
J
,
Willeit
J
,
Berek
A
,
Schmutzhard
E
,
Mutz
NJ
:
Polyneuropathies in critically ill patients: A prospective evaluation.
Intensive Care Med
1996
;
22
:
849
55
41.
Butler
SG
,
Stuart
A
,
Leng
X
,
Wilhelm
E
,
Rees
C
,
Williamson
J
,
Kritchevsky
SB
:
The relationship of aspiration status with tongue and handgrip strength in healthy older adults.
J Gerontol A Biol Sci Med Sci
2011
;
66
:
452
8
42.
Lee
JJ
,
Waak
K
,
Grosse-Sundrup
M
,
Xue
F
,
Lee
J
,
Chipman
D
,
Ryan
C
,
Bittner
EA
,
Schmidt
U
,
Eikermann
M
:
Global muscle strength but not grip strength predicts mortality and length of stay in a general population in a surgical intensive care unit.
Phys Ther
2012
;
92
:
1546
55
43.
Baldwin
CE
,
Paratz
JD
,
Bersten
AD
:
Muscle strength assessment in critically ill patients with handheld dynamometry: An investigation of reliability, minimal detectable change, and time to peak force generation.
J Crit Care
2013
;
28
:
77
86
44.
Reinhardt
GF
,
Myscofski
JW
,
Wilkens
DB
,
Dobrin
PB
,
Mangan
JE
Jr
,
Stannard
RT
:
Incidence and mortality of hypoalbuminemic patients in hospitalized veterans.
JPEN J Parenter Enteral Nutr
1980
;
4
:
357
9
45.
Hund
E
:
Neurological complications of sepsis: Critical illness polyneuropathy and myopathy.
J Neurol
2001
;
248
:
929
34
46.
de Letter
MA
,
Schmitz
PI
,
Visser
LH
,
Verheul
FA
,
Schellens
RL
,
Op de Coul
DA
,
van der Meché
FG
:
Risk factors for the development of polyneuropathy and myopathy in critically ill patients.
Crit Care Med
2001
;
29
:
2281
6
47.
Leder
SB
:
Incidence and type of aspiration in acute care patients requiring mechanical ventilation via a new tracheotomy.
Chest
2002
;
122
:
1721
6
48.
Marik
PE
:
Aspiration pneumonitis and aspiration pneumonia.
N Engl J Med
2001
;
344
:
665
71
49.
Grosse-Sundrup
M
,
Henneman
JP
,
Sandberg
WS
,
Bateman
BT
,
Uribe
JV
,
Nguyen
NT
,
Ehrenfeld
JM
,
Martinez
EA
,
Kurth
T
,
Eikermann
M
:
Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study.
BMJ
2012
;
345
:
e6329
50.
Smith Hammond
CA
,
Goldstein
LB
:
Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia: ACCP evidence-based clinical practice guidelines.
Chest
2006
;
129
(
1 suppl
):
154
68S
51.
Robbins
J
,
Kays
S
,
McCallum
S
:
Team management of dysphagia in the institutional setting.
J Nutr Elder
2007
;
26
:
59
104
52.
Isono
S
,
Tanaka
A
,
Tagaito
Y
,
Ishikawa
T
,
Nishino
T
:
Influences of head positions and bite opening on collapsibility of the passive pharynx.
J Appl Physiol
2004
;
97
:
339
46
53.
Palmer
JB
,
Drennan
JC
,
Baba
M
:
Evaluation and treatment of swallowing impairments.
Am Fam Physician
2000
;
61
:
2453
62
54.
Jafari
S
,
Prince
RA
,
Kim
DY
,
Paydarfar
D
:
Sensory regulation of swallowing and airway protection: A role for the internal superior laryngeal nerve in humans.
J Physiol
2003
;
550
(
Pt 1
):
287
304
55.
Barquist
E
,
Brown
M
,
Cohn
S
,
Lundy
D
,
Jackowski
J
:
Postextubation fiberoptic endoscopic evaluation of swallowing after prolonged endotracheal intubation: A randomized, prospective trial.
Crit Care Med
2001
;
29
:
1710
3
56.
Ajemian
MS
,
Nirmul
GB
,
Anderson
MT
,
Zirlen
DM
,
Kwasnik
EM
:
Routine fiberoptic endoscopic evaluation of swallowing following prolonged intubation: Implications for management.
Arch Surg
2001
;
136
:
434
7
57.
Trapl
M
,
Enderle
P
,
Nowotny
M
,
Teuschl
Y
,
Matz
K
,
Dachenhausen
A
,
Brainin
M
:
Dysphagia bedside screening for acute-stroke patients: The Gugging Swallowing Screen.
Stroke
2007
;
38
:
2948
52
58.
Rugiu
MG
:
Role of videofluoroscopy in evaluation of neurologic dysphagia.
Acta Otorhinolaryngol Ital
2007
;
27
:
306
16
59.
Langmore
SE
,
Schatz
K
,
Olsen
N
:
Fiberoptic endoscopic examination of swallowing safety: A new procedure.
Dysphagia
1988
;
2
:
216
9
60.
Bastian
RW
:
The videoendoscopic swallowing study: An alternative and partner to the videofluoroscopic swallowing study.
Dysphagia
1993
;
8
:
359
67
61.
Aviv
JE
:
Prospective, randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia.
Laryngoscope
2000
;
110
:
563
74